TheEdgeResearch
Home / Stocks / TCNAF

TransCanna Holdings Inc. (TCNAF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$11,974
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-4.29
52-Wk Range
0.0001-0.0001
CEO
James Robert Blink
Country
CA
Currency
USD

TransCanna Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in West Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $11,974. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of -377.4%. Its beta of -4.29 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.04
Price / Sales
0.30
Price / Book
0.17
EV / EBITDA
-1.96
Gross margin
-21.3%
Operating margin
-258.1%
Net margin
-377.4%
Return on equity
Debt / equity
5.75
Current ratio
0.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
19
IPO date
2019-03-04
Headquarters
West Vancouver, BC, CA
About TransCanna Holdings Inc.

TransCanna Holdings Inc., operating through its various subsidiaries, offers essential logistical and supply chain management services for the cannabis industry across the United States. With a primary focus on California, the company delivers comprehensive support, including brand development, marketing strategies, and the transportation and distribution of cannabis products. These services are tailored for state-licensed businesses actively involved in the cultivation, manufacturing, and retail of cannabis. The enterprise was founded in 2017 and has its corporate headquarters situated in West Vancouver, Canada.

Comparable companies

TransCanna Holdings Inc. is most often compared with the following Healthcare names:

DBCCFDXBRFELIXFFLOOFINISMILFFMRMDSNNVFSPBBFVEXTF
More research on TCNAF
TCNAF technical analysis TCNAF TheEdge Score Compare against peers
Open full interactive analysis & DCF →